Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Atara Biotherapeutics, Inc. (ATRA) had Return on Tangible Equity of -6.81% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$17.57M |
|
$2.39M |
|
$0.55M |
|
$17.02M |
|
$14.38M |
|
$3.20M |
|
$-0.81M |
|
$2.39M |
|
$2.39M |
|
$2.39M |
|
$2.39M |
|
$2.39M |
|
$2.39M |
|
$3.20M |
|
$3.43M |
|
12.20M |
|
12.31M |
|
$0.20 |
|
$0.19 |
|
| Balance Sheet Financials | |
$24.77M |
|
$0.18M |
|
$12.13M |
|
$36.90M |
|
$14.56M |
|
-- |
|
$57.38M |
|
$71.94M |
|
$-35.04M |
|
$-35.04M |
|
$-35.04M |
|
6.98M |
|
| Cash Flow Statement Financials | |
$-35.46M |
|
$12.13M |
|
$15.05M |
|
$25.18M |
|
$16.90M |
|
$-8.27M |
|
$7.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
96.85% |
|
18.19% |
|
18.19% |
|
-- |
|
13.60% |
|
13.58% |
|
$-35.11M |
|
-- |
|
-- |
|
-- |
|
0.48 |
|
-- |
|
-- |
|
-- |
|
-6.81% |
|
|
Return on Tangible Equity |
-6.81% |
6.47% |
|
-6.81% |
|
$-5.02 |
|
$-2.85 |
|
$-2.88 |
|